# AMPICILLIN SODIUM
> **ANDA062772** · Abbreviated New Drug Application (Generic) · Sponsor: HQ SPECLT PHARMA · Approved 1993-04-15
## Drug
- **FDA Application Number:** ANDA062772
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** AMPICILLIN SODIUM
- **Generic name:** AMPICILLIN
- **Active ingredients:** AMPICILLIN SODIUM
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Discontinued
- **Sponsor:** HQ SPECLT PHARMA
- **Manufacturer:** WG Critical Care, LLC
- **First approval:** 1993-04-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=062772)
---
*MORVS · CC0 1.0*